David C. Linehan
Impact in
- Oncology top 0.1%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Immunology top 0.2%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Phagocytosis and Immune Regulation
Papers in
- Oncology 83
- Pancreatic and Hepatic Oncology Research 54
- Cancer Immunotherapy and Biomarkers 22
- Immunology 41
- Immunotherapy and Immune Responses 23
- Immune cells in cancer 15
- Immune Cell Function and Interaction 13
- Co-authors
- Steven M. Strasberg (45 shared papers)William G. Hawkins (43 shared papers)Peter S. Goedegebuure (25 shared papers)Jeffrey A. Drebin (8 shared papers)Timothy J. Eberlein (21 shared papers)David Glenn DeNardo (11 shared papers)Brian A. Belt (25 shared papers)Andrea Wang‐Gillam (14 shared papers)
- Journals
- Journal of the American College of Surgeons (17 papers)Annals of Surgery (15 papers)HPB (12 papers)Annals of Surgical Oncology (11 papers)The Journal of Immunology (7 papers)
- Partner nations
- United StatesUnited KingdomIreland
In The Last Decade
David C. Linehan
172 papers receiving 16.5k citations
David C. Linehan's Hit Papers
Peers
Comparison fields: 5 of 143
- Oncology 9.4k
- Immunology 5.8k
- Hepatology 1.4k
- Cancer Research 1.9k
- Pulmonary and Respiratory Medicine 1.9k
Countries citing papers authored by David C. Linehan
This map shows the geographic impact of David C. Linehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Linehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Linehan more than expected).
Fields of papers citing papers by David C. Linehan
This network shows the impact of papers produced by David C. Linehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Linehan. The network helps show where David C. Linehan may publish in the future.
Co-authors
The 25 scholars most cited alongside David C. Linehan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 178 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma Hit paper breakdown → | 2002 | 1260 |
| 2 | CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models Hit paper breakdown → | 2014 | 1102 |
| 3 | Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses Hit paper breakdown → | 2012 | 813 |
| 4 | Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement Hit paper breakdown → | 2009 | 723 |
| 5 | Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial Hit paper breakdown → | 2016 | 694 |
| 6 | The Accordion Severity Grading System of Surgical Complications Hit paper breakdown → | 2009 | 585 |
| 7 | Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis Hit paper breakdown → | 2013 | 514 |
| 8 | 2004 | 494 | |
| 9 | 2017 | 407 | |
| 10 | 2015 | 402 | |
| 11 | 1995 | 390 | |
| 12 | 2005 | 386 | |
| 13 | 2009 | 375 | |
| 14 | 1998 | 366 | |
| 15 | 2003 | 280 | |
| 16 | 2012 | 233 | |
| 17 | 1999 | 212 | |
| 18 | Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot Hit paper breakdown → | 2022 | 204 |
| 19 | 2013 | 201 | |
| 20 | 2017 | 188 |
About David C. Linehan
David C. Linehan is a scholar working on Oncology, Immunology, Hepatology, Surgery and Pulmonary and Respiratory Medicine, having authored 178 papers that have together received 17.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (54 papers), Immunotherapy and Immune Responses (23 papers), Cancer Immunotherapy and Biomarkers (22 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Immune cells in cancer (15 papers), Immune Cell Function and Interaction (13 papers), Gallbladder and Bile Duct Disorders (9 papers) and Neuroendocrine Tumor Research Advances (8 papers). The work is most often cited by research in Oncology (9.4k citations), Immunology (5.8k citations), Hepatology (1.4k citations), Cancer Research (1.9k citations) and Pulmonary and Respiratory Medicine (1.9k citations). David C. Linehan has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Steven M. Strasberg, William G. Hawkins, Peter S. Goedegebuure, Jeffrey A. Drebin, Timothy J. Eberlein, David Glenn DeNardo, Brian A. Belt, Andrea Wang‐Gillam, Simon Peter Goedegebuure and Jonathan B. Mitchem. Their work appears in journals such as Journal of the American College of Surgeons, Annals of Surgery, HPB, Annals of Surgical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.